MAPK1 and cancer: Activatingmutations in the genes of upstream receptor tyrosine kinases or in the genesencoding the RAS, RAF, MEK and ERK proteins can lead to aberrant activation ofERK1/2 in tumors and, taken together, constitute the most frequent group ofmutations in human cancer cells.